Sage Therapeutics Inc. sell Citigroup Inc.
Start price
29.05.24
/
50%
€10.05
Target price
29.05.25
€7.37
Performance (%)
-42.75%
End price
30.05.25
€5.75
Summary
This prediction ended on 30.05.25 with a price of €5.75. The SELL prediction by Citigroup_Inc_ for Sage Therapeutics Inc. performed very well with a performance of -42.75%. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% |
Comments by Citigroup_Inc_ for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) is now covered by analysts at Citigroup Inc.. They set a "sell" rating and a $8.00 price target on the stock.
Ratings data for SAGE provided by MarketBeat
In the thread Trading Sage Therapeutics Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten

